Leggett Thomas

Stoke Therapeutics, Inc. · Chief Financial Officer

Leggett Thomas is listed in public filings as officer: Chief Financial Officer. This Leggett Thomas insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Stoke Therapeutics, Inc. (STOK). Investors use Leggett Thomas's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Stoke Therapeutics, Inc.STOK$334k10.2k sharesSellMar 18, 2026$1.2K37 shares$32.85--
Stoke Therapeutics, Inc.STOK$325k10.4k sharesSellMar 18, 2026$68.0K2.2k shares$31.28--
Stoke Therapeutics, Inc.STOK$325k10.2k sharesSellMar 18, 2026$5.5K172 shares$31.79--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Stoke Therapeutics, Inc.STOK$441k13.5k sharesSellMar 17, 2026$41.7K1.3k shares$32.74--
Stoke Therapeutics, Inc.STOK$419k12.6k sharesSellMar 17, 2026$30.8K922 shares$33.38--
Stoke Therapeutics, Inc.STOK--14.8k sharesGrant / ExerciseMar 15, 2026Disclosure amount unavailable14.8k shares----
Stoke Therapeutics, Inc.STOK$1.9M60k sharesGrant / ExerciseFeb 17, 2026$1.9M60k shares$31.09--
Stoke Therapeutics, Inc.STOK--40k sharesGrant / ExerciseFeb 17, 2026Disclosure amount unavailable40k shares----
Stoke Therapeutics, Inc.STOK$741k89k sharesGrant / ExerciseMar 20, 2025$741.4K89k shares$8.33--
Stoke Therapeutics, Inc.STOK--59k sharesGrant / ExerciseMar 20, 2025Disclosure amount unavailable59k shares----
Leggett Thomas | TradingNote